Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
06/2010
06/02/2010EP1879893B1 Method for making 1-substituted 1h-imidazo[4,5-c]quinolin-4-amine compounds and intermediates therefor
06/02/2010EP1833477B1 Pyrazolo-heteroaryl compounds useful to treat tnf-alpha and il-1 mediated diseases
06/02/2010EP1644012B1 Quaternary chelidonine and alkaloid derivatives, process for their preparation and their use in the preparation of medicaments
06/02/2010EP1225174B2 Anhydrous mirtazapine crystals and process for the production thereof
06/02/2010CN1835951B Isethionate salt of a selective CDK4 inhibitor
06/02/2010CN101717398A Sophocarpine-series derivative as well as preparation method and purposes thereof
06/02/2010CN101717397A Substituted pyridino-[2',1':2,3] imidazo[4,5-c] isoquinolone compounds, method for synthesizing same, use of same and medicinal composition having same
06/02/2010CN101279973B Preparation of 1,8-diazabicyclo[5.4.0] hendecene
06/01/2010US7728141 Substituted naphthyridinone derivatives
06/01/2010US7728140 3-(carboxy or carbamoyl)-5-amino-1H-pyrrolo(2,3-b)pyridines; cancer, Alzheimer's disease, viral infections, autoimmune diseases and neurodegenerative disorders; chemical libraries of these compounds
06/01/2010US7728139 for use as latent pigments; photocopiers
06/01/2010US7728003 8-Indan-5-yl-2-[4-(4-methyl-piperazin-1-yl)-propylamino]-5-oxo-5,8-dihydro-pyrido[2,3-d]pyrimidine-6-carboxylic acid amide; antiinflammatory, anticarcinogenic agent, cardiovascular disease; glomerulonephritis, immune nephritis, rheumatoid arthritis, asthma, pancreatitis, HIV infection, psoriasis
06/01/2010US7728002 peroxisome proliferator activated receptors modulators such as 1-(6-Benzothiazolylsulfonyl)-5-chloro-1H-pyrrolo[3,2-b]pyridine-2-butanoic acid, methyl ester, used for treating atherosclerosis, myocardial infarction, hypertension and cerebral vascular diseases
06/01/2010US7728000 compounds which intercalate between DNA base pairs, resulting in an interruption of transcription, replication and/or topoisomerase activity; antiproliferative and antitumor agents
06/01/2010US7727999 substituted 1,3,8-triaza-spiro[4.5]decan-2-one compounds, used as selective serotonin receptor antagonists, used rfor the treatment of schizophrenia, psychosis, headaches, hypertension, thrombosis, vasospasm, depression, anxiety, sleep disorders and appetite disorders
06/01/2010US7727997 N,N′-substituted-1,3-diamino-2-hydroxypropane derivatives
06/01/2010US7727989 4-benzimidazol-2-yl-pyridazine-3-one-derivatives, production and use thereof in medicaments
06/01/2010US7727985 For therapy of inflammatory disease and cancer
06/01/2010US7727980 Tricyclic androgen receptor modulator compounds and methods
06/01/2010CA2560008C Tetrahydronaphthyridine derivatives as cholesteryl ester transfer protein inhibitors
06/01/2010CA2515841C Novel 2-pyridine carboxamide derivatives
06/01/2010CA2481217C Process for preparing acid salts of gemifloxacin
06/01/2010CA2448737C Viral polymerase inhibitors
06/01/2010CA2423007C Spiro derivatives and adhesion molecule inhibitors containing the same as effective ingredients
06/01/2010CA2409827C Arylmethylamine derivatives for use as tryptase inhibitors
05/2010
05/27/2010WO2010060098A1 Antioxidant camptothecin derivatives and antioxidant antineoplastic nanospheres thereof
05/27/2010WO2010059788A1 Pyrazolopyridine pi3k inhibitor compounds and methods of use
05/27/2010WO2010059773A1 Aryl methyl benzoquinazolinone m1 receptor positive allosteric modulators
05/27/2010WO2010059771A1 Substituted pyrrolo[2,3-b]-pyridines and-pyrazines
05/27/2010WO2010059611A2 Inhibitors of diacylglycerol acyltransferase
05/27/2010WO2010059503A2 PROCESS FOR MAKING (R) -3-(2,3-DIHYDROXYPROPYL)-6-FLUORO-5-(2-FLOURO-4-IODOPHENYLAMINO)-8-METHYLPYRIDO[2,3-d]PYRIMIDINE-4,7(3H,8H)-DIONE AND INTERMEDIATES THEREOF
05/27/2010WO2010058858A1 Novel pyrazole-3-carboxamide derivative having 5-ht2b receptor antagonist activity
05/27/2010WO2010058846A1 4,6-diaminonicotinamide compound
05/27/2010WO2010058787A1 Organic electroluminescent element
05/27/2010WO2010058333A1 Lactams as beta secretase inhibitors
05/27/2010WO2010057877A1 7-pyridinyl- or phenyl- substituted triazolo [1, 5 -a] pyridines as pi3k inhibitors
05/27/2010WO2010057669A1 Systems for the light-induced separation of charges
05/27/2010WO2009140624A3 Glucokinase activators
05/27/2010US20100130740 Process for preparation of risperidone
05/27/2010US20100130738 Pyrazolone derivative and pde inhibitor containing the same as active ingredient
05/27/2010US20100130737 Regulating Agent of GPR34 Receptor Function
05/27/2010US20100130543 Pyrazole carboxamide inhibitors of factor xa
05/27/2010US20100130540 Azaquinolinone derivatives and uses thereof
05/27/2010US20100130539 Imidazopyridine inhibitors of iap
05/27/2010US20100130538 Bicyclic compound and pharmaceutical use thereof
05/27/2010US20100130518 Mapk/erk kinase inhibitors
05/27/2010US20100130517 New 4,8-diphenyl-polyazanaphthalene derivatives
05/27/2010US20100130513 Benzimidazoles and analogs thereof as antivirals
05/27/2010US20100130512 Fused-ring heterocycle opioids
05/27/2010US20100130503 New fluorene derivatives, compositions containing the same and use thereof as inhibitors of the protein chaperone hsp 90
05/27/2010US20100130501 Novel 3-amino-pyrrolo[3,4-c]pyrazole-5(1h, 4h, 6h) carbaldehyde derivatives
05/27/2010US20100130495 Compounds 563
05/27/2010US20100130489 Imidazolo-heteroaryl derivatives with antibacterial properties
05/27/2010US20100130483 Novel diazabicyclic aryl derivatives
05/27/2010US20100130482 Diazabicyclic aryl derivatives as nicotinic acetylcholine receptor ligands
05/27/2010US20100130481 Anticonvulsant and anxiolytic methods of using receptor subtype selective agents
05/27/2010US20100130473 Compounds
05/27/2010US20100130469 2, 6-naphthridine derivatives
05/27/2010US20100130465 2-aminothiazole-4-carboxylic amides as protein kinase inhibitors
05/27/2010US20100130420 Novel chimeric ligand-gated ion channels and methods of use thereof
05/27/2010US20100129800 Polymers and their use as fluorescent labels
05/27/2010US20100126880 Dna complexing agents
05/27/2010US20100126378 Pigments for Non-Aqueous Inks and Coatings
05/27/2010DE102008058454A1 Use of an alpha effective compound, and an isoxazolidine compound e.g. as an electron donor group in light-driven systems for charge separation, to extract solar energy, preferably in photovoltaic cells, and for mass coloring of polymers
05/27/2010CA2744154A1 Pyrazolopyridine pi3k inhibitor compounds and methods of use
05/27/2010CA2743584A1 Lactams as beta secretase inhibitors
05/27/2010CA2743562A1 Aryl methyl benzoquinazolinone m1 receptor positive allosteric modulators
05/27/2010CA2743497A1 Inhibitors of diacylglycerol acyltransferase
05/27/2010CA2742785A1 Process for making (r) -3-(2,3-dihydroxypropyl)-6-fluoro-5-(2-flouro-4-iodophenylamino)-8-methylpyrido[2,3-d]pyrimidine-4,7(3h,8h)-dione and intermediates thereof
05/27/2010CA2741511A1 Novel pyrazole-3-carboxamide derivative having 5-ht2b receptor antagonist activity
05/26/2010EP2189459A1 Stable crystalline salt of 5-methyll-(6S)-tetrahydrofolic acid
05/26/2010EP2189451A1 Benzamide derivatives, their preparation and uses in medicine thereof
05/26/2010EP2188295A2 Pyridine derivatives and methods of use thereof
05/26/2010EP2188286A1 Process for the preparation of pyrido [2, 1-a]isoquinoline derivatives and polymorphic froms thereof
05/26/2010EP2188285A1 Pyrazoloquinoline and pyrazolonaphthyridine derivatives as gaba alpha ligands
05/26/2010EP2188284A2 Tricyclic heterocyclic compounds as gaba a modulators
05/26/2010EP2188283A1 Annelated pyridazines for the treatment of tumors driven by inappropriate hedgehog signalling
05/26/2010EP2188280A2 Imidazopyridinones
05/26/2010EP2188274A1 Viral polymerase inhibitors
05/26/2010EP2187883A2 Nitrogen containing bicyclic chemical entities for treating viral infections
05/26/2010EP2079724B1 Substituted pyridone compounds and methods of use
05/26/2010EP1896470B1 Pyrrolopyridine derivatives as protein kinase inhibitors
05/26/2010EP1861400B1 Crystal forms of an imidazole derivative
05/26/2010EP1685135B1 TETRAHYDRO-FURO[3,4-d]DIOXOLE COMPOUNDS AND COMPOSITIONS AND METHOD FOR INHIBITING PLATELET AGGREGATION
05/26/2010EP1315709B1 Aminoalkylbenzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same
05/26/2010CN1953983B 1-heterocyclyl-1,5-dihydro-pyrido[3,2-b]indol-2-ones
05/26/2010CN1867331B Thalidomide analogs as TNF-alpha modulators
05/26/2010CN1713907B N-substituted pyrrolidin derivatives as dipeptidyl peptidase IV inhibitors
05/26/2010CN1649883B Bicyclic 6-alkylidene-penems as lactamases inhibitors
05/26/2010CN1642580B Radiolabelled quinoline and quinolinone derivatives and their use as metabotropic glutamate receptor ligands
05/26/2010CN1553814B Remedies for arteriosclerosis
05/26/2010CN101715451A Novel pyridopyrazine derivatives, process of manufacturing and uses thereof
05/26/2010CN101715450A Azaindole derivatives as cftr modulators
05/26/2010CN101712682A Method for synthesizing tasosartan
05/26/2010CN101712681A Chemical synthesis method of paliperidone intermediate
05/26/2010CN101712680A Green method for synthesizing pyrido [1,2-a] pyrimidine-4-keone derivant
05/26/2010CN101712660A Derivatives of piperidinyl- and piperazinyl-alkyl carbamates, preparation methods thereof and application of same in therapeutics
05/26/2010CN101712648A Synthesis method of azepine anthraquinone
05/26/2010CN101157694B Carboline compound, application and preparation method thereof
05/26/2010CN101058580B Method of extracting matrine by ultrasound wave method
1 ... 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 ... 646